Mega Lifesciences PCL Statistics

Total Valuation

Mega Lifesciences PCL has a market cap or net worth of THB 34.00 billion. The enterprise value is 30.72 billion.

Market Cap	34.00B
Enterprise Value	30.72B

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	Aug 23, 2024

Share Statistics

Mega Lifesciences PCL has 871.87 million shares outstanding.

Shares Outstanding	871.87M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	60.15%
Owned by Institutions (%)	12.20%
Float	347.43M

Valuation Ratios

The trailing PE ratio is 17.01 and the forward PE ratio is 13.56. Mega Lifesciences PCL's PEG ratio is 3.08.

PE Ratio	17.01
Forward PE	13.56
PS Ratio	2.17
PB Ratio	3.47
P/FCF Ratio	n/a
PEG Ratio	3.08

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.43, with an EV/FCF ratio of 12.71.

EV / Earnings	15.37
EV / Sales	1.96
EV / EBITDA	9.43
EV / EBIT	10.19
EV / FCF	12.71

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.04.

Current Ratio	2.25
Quick Ratio	1.50
Debt / Equity	0.04
Debt / EBITDA	0.13
Debt / FCF	0.17
Interest Coverage	109.83

Financial Efficiency

Return on equity (ROE) is 21.17% and return on invested capital (ROIC) is 19.08%.

Return on Equity (ROE)	21.17%
Return on Assets (ROA)	12.70%
Return on Capital (ROIC)	19.08%
Revenue Per Employee	17.43M
Profits Per Employee	2.22M
Employee Count	900
Asset Turnover	1.06
Inventory Turnover	2.32

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.19%
50-Day Moving Average	38.75
200-Day Moving Average	39.80
Relative Strength Index (RSI)	48.01
Average Volume (20 Days)	814,726

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mega Lifesciences PCL had revenue of THB 15.68 billion and earned 2.00 billion in profits. Earnings per share was 2.29.

Revenue	15.68B
Gross Profit	7.35B
Operating Income	3.02B
Pretax Income	2.32B
Net Income	2.00B
EBITDA	3.18B
EBIT	3.02B
Earnings Per Share (EPS)	2.29

Full Income Statement

Balance Sheet

The company has 3.69 billion in cash and 413.21 million in debt, giving a net cash position of 3.28 billion or 3.76 per share.

Cash & Cash Equivalents	3.69B
Total Debt	413.21M
Net Cash	3.28B
Net Cash Per Share	3.76
Equity (Book Value)	9.79B
Book Value Per Share	11.23
Working Capital	5.95B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.67 billion and capital expenditures -249.29 million, giving a free cash flow of 2.42 billion.

Operating Cash Flow	2.67B
Capital Expenditures	-249.29M
Free Cash Flow	2.42B
FCF Per Share	2.77

Full Cash Flow Statement

Margins

Gross margin is 46.84%, with operating and profit margins of 19.22% and 12.75%.

Gross Margin	46.84%
Operating Margin	19.22%
Pretax Margin	14.79%
Profit Margin	12.75%
EBITDA Margin	20.31%
EBIT Margin	19.22%
FCF Margin	15.42%

Dividends & Yields

This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 4.05%.

Dividend Per Share	1.60
Dividend Yield	4.05%
Dividend Growth (YoY)	-3.03%
Years of Dividend Growth	4
Payout Ratio	69.81%
Buyback Yield	n/a
Shareholder Yield	4.05%
Earnings Yield	5.88%
FCF Yield	7.11%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mega Lifesciences PCL has an Altman Z-Score of 7.04.

Altman Z-Score	7.04
Piotroski F-Score	n/a